Carroll Financial Associates, Inc. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 247 filers reported holding HAEMONETICS CORP in Q4 2017. The put-call ratio across all filers is 1.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
Carroll Financial Associates, Inc. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2021$2,000
+100.0%
19
+18.8%
0.00%
Q4 2020$1,0000.0%160.0%0.00%
Q3 2020$1,000
-90.0%
16
-82.6%
0.00%
-100.0%
Q3 2018$10,000
+11.1%
92
-14.0%
0.00%0.0%
Q2 2018$9,000
+28.6%
1070.0%0.00%0.0%
Q1 2018$7,000
+600.0%
107
+328.0%
0.00%
Q4 2017$1,0000.0%250.0%0.00%
Q3 2017$1,000250.0%0.00%
Q2 2017$0250.00%
Other shareholders
HAEMONETICS CORP shareholders Q4 2017
NameSharesValueWeighting ↓
Bridge City Capital, LLC 40,541$5,114,0002.20%
Lisanti Capital Growth, LLC 53,385$6,734,0002.20%
Nitorum Capital, L.P. 279,510$35,257,0002.05%
CROWN ADVISORS MANAGEMENT, INC. 20,000$2,523,0001.69%
Millrace Asset Group, Inc. 11,400$1,438,0001.69%
COOKSON PEIRCE & CO INC 145,884$18,402,0001.61%
Endurant Capital Management LP 32,594$4,111,0001.48%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 111,000$14,002,0001.38%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 110,065$13,884,0001.37%
EMERALD ADVISERS, LLC 203,640$25,687,0001.20%
View complete list of HAEMONETICS CORP shareholders